Decreased ADAMTS13 Activity During COVID-19 Infection Predicts Future Major Cerebrovascular and Cardiovascular Adverse Events (P1-13.010)
To examine whether ADAMTS13 activity levels measured at the time of acute SARS-CoV-2 infection predict major cerebrovascular and cardiovascular adverse events (MACE) at 42 months.
Authors
- Claire Delpirou Nouh (ORCID: https://orcid.org/0000-0002-8146-9702)
- Philion Gatchoff
- Angelia Kirkpatrick (ORCID: https://orcid.org/0000-0003-2500-6380)
- Călin I. Prodan (ORCID: https://orcid.org/0000-0002-7749-2061)
- Leslie Guthery
- James N. George (ORCID: https://orcid.org/0000-0002-4243-2691)
- Fabiola Donna-Ferreira
- Chao Xu
- Jason Sharps
- Andrea S. Vincent (ORCID: https://orcid.org/0000-0001-9693-5764)
Institutions
- Oklahoma City VA Medical Center (US)
- University of Oklahoma (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211127
- Primary Topic
- Apelin-related biomedical research
- Type
- article
- Field-Weighted Citation Impact
- 0.00